While maintaining the previously described linker consisting of suberic acid, lysine and two L-phenylalanine building blocks, the DOTAGA conjugate showed significantly improved tumour uptake when compared to the DOTA equivalent and similar performance compared to PSMA-11. Here, FOLH1 is linked to neoplasm.